Classifieds | Archives | Jobs | About TGT | Contact | Subscribe
 | 
Last updated 1 hour, 59 minutes ago
Printer Friendly Version | TGT@Twitter | RSS Feed |
HOME LOCAL MIDEAST ASIA WORLD BUSINESS SPORT OPINION WRITERS
New cervical cancer screening proposed, hospital launches awareness campaign
By Mariecar Jara-Puyod May 03, 2016
 Print    Send to Friend

DUBAI: The entry and approval of a new screening or test against cervical cancer is being discussed with Abu Dhabi health authorities, according to a Tawam Hospital senior official.

Meanwhile on Monday, the Zulekha Hospital Group (ZHG) launched the third edition of its “Smear Don’t Fear” campaign that aims at not only educating the community about preventions and treatments against the disease caused by the human papillomavirus (HPV) but more importantly conducting free cervical screenings with gynaecologist consultations until June 30, 2016.

From the launch, Dubai Health Authority-Health Regulation and Dubai Medical Tourism Project director Dr Layla Al Marzouki said, “We should aim for 100 per cent vaccination coverage in the UAE.”

The vaccination has been a Abu Dhabi public health policy since 2008.

The inoculations which come in three doses are recommended for girls from age nine and which may be taken until they are age 36 while for the boys are from ages nine and 21.

Direct from her clinic in California, Dr Pamela Munster who has been the ZHG spokesperson on cancer awareness programmes emphasised that boys must also be vaccinated because not doing so would not address the rising concerns about cervical cancer, mostly diagnosed among people with multiple partners.

On the new screening or test, Tawam Hospital-Obstetrics & Gynaecology Department chairman Dr Saad Ghazal told The Gulf Today, “We already started talks with the Health Authority Abu Dhabi. We had presented to them the difference between smear screening and the HPV screening which is more accurate.”

The gynaecologist-oncologist mentioned the HPV test when he was the lecturer at a recently-held Roche Diagnostics Middle East Media Talks.

Ghazal said the HPV test was approved by the US Food and Drug Administration in 2014 after a series of clinical trials in many parts of the world.
 

Add this page to your favorite Social Bookmarking websites
Comments
 
Post a comment
 
Name:
Country:
City:
Email:
Comment:
 
    
    
Related Stories
Meet to highlight progress in forensic medicine
DUBAI: The organising committee of Emirates International Forensic Science Conference and Exhibition has announced the agenda of its first edition that will be held under..
Doctors discuss colorectal cancer
ABU DHABI: Misconceptions about colorectal cancer screening are leading many Emirati nationals to forgo a procedure that could potentially save their lives, warn healthca..
Ministry halts imports of food products from Brazilian firms
DUBAI: The Ministry of Climate Change and Environment, MoCCAE, has taken a number of precautionary measures on imported food products from Brazil, following the informati..
Paediatric, neonatal conference kicks off
DUBAI: A total of 400 participants took part in the“3rd Latifa Hospital International Pediatric and Neonatal Conference” (LHPNC 2017), which kicked off on Thursday. Th..
‘Mandatory Vitamin D screening for all patients’
ABU DHABI: The “Abu Dhabi Annual International Conference on Vitamin D Deficiency and Human Health,” held in Abu Dhabi on March 17-18, 2017, stressed on the need of patie..
FRONTPAGE
 
GALLERY
 
PANORAMA
 
TIME OUT
 
SPORT
 
 
Advertise | Copyright